Right-Sided Endocarditis involving Eustachian Valve Following the Use of a Central Venous Line.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
14 Sep 2020
Historique:
entrez: 14 9 2020
pubmed: 15 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

BACKGROUND Right-sided endocarditis is a well-known condition that occurs predominantly in intravenous drug users and patients with cardiovascular implantable electronic devices, central venous lines, and congenital heart disease. Most cases involve the tricuspid valve apparatus. Eustachian valve endocarditis (EVE) is a very rare and underdiagnosed condition with only a few previously reported cases. CASE REPORT We present a rare case of 2-sided infective thromboembolism from Staphylococcus aureus endocarditis involving both the eustachian and mitral valves in a 27-year-old man with mitochondrial neurogastrointestinal encephalopathy disease, which is a rare mitochondrial disease. CONCLUSIONS Endocarditis involving the eustachian valve is rare and presents a significant dilemma in diagnosis and treatment. Late diagnosis can lead to missed thromboembolic events and can have a significant impact on treatment and prognosis. In cases with high suspicion, early use of transesophageal echocardiography and chest CT can greatly advance diagnosis. The international guidelines do not specifically address patients with EVE; therefore, we recommend that the endocarditis team should be involved in any case of EVE to customize a treatment strategy.

Identifiants

pubmed: 32925870
pii: 923465
doi: 10.12659/AJCR.923465
pmc: PMC7518643
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e923465

Références

Heart. 1999 Jan;81(1):91
pubmed: 10220552
Clin Cardiol. 1997 Jun;20(6):579-80
pubmed: 9181271
Am Heart J. 2001 Dec;142(6):1037-40
pubmed: 11717609
Echocardiography. 2006 Mar;23(3):256-7
pubmed: 16524401
Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):202-207
pubmed: 30957862
Tex Heart Inst J. 2001;28(1):57-9
pubmed: 11330744
Can J Cardiol. 2009 Dec;25(12):e422-3
pubmed: 19960137
J Am Soc Echocardiogr. 2001 Oct;14(10):1042-3
pubmed: 11593213
Int J Cardiol. 2006 May 24;109(3):406-7
pubmed: 15993961
Cardiovasc Ultrasound. 2005 Sep 19;3:30
pubmed: 16171516
J Cardiovasc Dis Res. 2011 Jul;2(3):181-5
pubmed: 22022147
Br Heart J. 1986 Dec;56(6):561-2
pubmed: 3801248
J Am Soc Echocardiogr. 1996 Mar-Apr;9(2):206-8
pubmed: 8849620

Auteurs

Muhamad Mahamid (M)

Heart Institute, Emek Medical Center, Afula, Israel.

Jusinga Mashiah (J)

Department of Infectious Diseases, Emek Medical Center, Afula, Israel.

Ehud Rozner (E)

Heart Institute, Emek Medical Center, Afula, Israel.

Mohamed Jabaren (M)

Heart Institute, Emek Medical Center, Afula, Israel.

Yoav Turgeman (Y)

Heart Institute, Emek Medical Center, Afula, Israel.
Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Ofir Koren (O)

Heart Institute, Emek Medical Center, Afula, Israel.
Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH